Literature DB >> 15009203

N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line.

Guillermina Forno1, Mariela Bollati Fogolin, Marcos Oggero, Ricardo Kratje, Marina Etcheverrigaray, Harald S Conradt, Manfred Nimtz.   

Abstract

GM-CSF is one of several naturally occurring glycoproteins that regulate leukocyte production, migration and function. It has been produced in different cell types, with different properties that depend on the production process used. The purpose of this work was to characterize the recombinant human GM-CSF from an engineered Chinese hamster ovary cell line grown in suspension and as adherent culture for the identification of the glycosylation sites and the definition of the glycosidic moiety, including the degree of site occupancy. Both preparations exhibited size heterogeneity in SDS/PAGE with multiple bands containing glycoprotein forms with either two or one N-glycosylation sites occupied. Minor low molecular mass forms completely lacked N-linked oligosaccharides but contained 1-3 O-linked glycans. Twelve differently charged isoforms were detected in isoelectric focusing gels. At least 16 glycoforms, differing in the number of Hex-HexNAc units (Deltam 365 Da), were detected in MALDI-TOF MS spectra of the desialylated GM-CSFs. MALDI-TOF MS and HPAEC-PAD analysis indicated the presence of predominantly tri- and tetraantennary N-linked oligosaccharide chains with and without N-acetyllactosamine repeat units and some 10% of biantennary oligosaccharides, all containing more than 90% proximal alpha1-6-linked fucose. The oligosaccharide patterns of both GM-CSF preparations were found to be very similar. More than 90% of terminal galactose residues of the N-glycans were found alpha2-3 sialylated with NeuNAc (93%) or NeuNGc (7%). Site specific glycosylation was analysed by electrospray ionization MS and it was found that in the mono glycosylated GM-CSF form more than 90% of the Asn37 were occupied by N-glycans. O-glycosylation at the N-terminus of the polypeptide was detected at Ser7 and Ser9 or Thr10, in the predominantly doubly O-glycosylated glycoprotein form. In the triply modified GM-CSF molecules, Ser5 was additionally O-glycosylated. The major difference between both preparations was found in the MALDI spectra of the desialylated glycoproteins, revealing a higher proportion of forms with a single N-glycosylation site occupied in the preparation derived from suspension culture. ESI-MS and MALDI-MS analysis of endoproteolytically cleaved peptides as well as MALDI-TOF MS of the intact glycoprotein demonstrated the N- and C-termini integrity of the GM-CSF preparations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009203     DOI: 10.1111/j.1432-1033.2004.03993.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Ion mobility mass spectrometry for extracting spectra of N-glycans directly from incubation mixtures following glycan release: application to glycans from engineered glycoforms of intact, folded HIV gp120.

Authors:  David J Harvey; Frank Sobott; Max Crispin; Antoni Wrobel; Camille Bonomelli; Snezana Vasiljevic; Christopher N Scanlan; Charlotte A Scarff; Konstantinos Thalassinos; James H Scrivens
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-08       Impact factor: 3.109

2.  GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

Authors:  Leander Meuris; Francis Santens; Greg Elson; Nele Festjens; Morgane Boone; Anaëlle Dos Santos; Simon Devos; François Rousseau; Evelyn Plets; Erica Houthuys; Pauline Malinge; Giovanni Magistrelli; Laura Cons; Laurence Chatel; Bart Devreese; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

3.  Characterization of a novel + 70 Da modification in rhGM-CSF expressed in E. coli using chemical assays in combination with mass spectrometry.

Authors:  Magdalena Widgren Sandberg; Jakob Bunkenborg; Stine Thyssen; Martin Villadsen; Thomas Kofoed
Journal:  Amino Acids       Date:  2021-08-28       Impact factor: 3.789

4.  A Novel Methanol-Free Platform for Extracellular Expression of rhGM-CSF in Pichia pastoris.

Authors:  Roghayeh Shirvani; Sajjad Yazdanpanah; Mohammad Barshan-Tashnizi; Maryam Shahali
Journal:  Mol Biotechnol       Date:  2019-07       Impact factor: 2.695

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

6.  Synthesis of granulocyte-macrophage colony-stimulating factor as homogeneous glycoforms and early comparisons with yeast cell-derived material.

Authors:  Qiang Zhang; Eric V Johnston; Jae-Hung Shieh; Malcolm A S Moore; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

7.  DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant.

Authors:  Abebe Genetu Bayih; Nada S Daifalla; Lashitew Gedamu
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

Review 8.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

9.  Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.

Authors:  Gözde Isik; Thijs van Montfort; Maikel Boot; Viviana Cobos Jiménez; Neeltje A Kootstra; Rogier W Sanders
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Granulocyte-macrophage colony stimulating factor (GM-CSF) is fully expressed in the genital tract, seminal plasma and spermatozoa of male pigs.

Authors:  Lorena Padilla; Jesús Martínez-Hernández; Isabel Barranco; Xiomara Lucas; Luis M Pastor; Heriberto Rodriguez-Martínez; Jordi Roca; Inmaculada Parrilla
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.